Press Releases

Teva and Active Biotech Announce First Patient Enrolled in Phase II Study Evaluating Laquinimod for Primary Progressive MS
April 23, 2015 20:00 (CEST)
Active Biotech AB Interim report January - March 2015
April 23, 2015 08:34 (CEST)
Active Biotech AB Interim report January - March 2015
April 23, 2015 08:30 (CEST)
Active Biotech and Ipsen announce their decision to discontinue the development of tasquinimod in prostate cancer
April 16, 2015 07:19 (CEST)
Active Biotech and Ipsen announce their decision to discontinue the development of tasquinimod in prostate cancer
April 16, 2015 07:00 (CEST)
Active Biotech AB Year-end report January - December 2014
February 11, 2015 08:36 (CET)
Active Biotech AB Year-end report January - December 2014
February 11, 2015 08:30 (CET)
Number of shares and votes in Active Biotech
January 30, 2015 08:39 (CET)
Number of shares and votes in Active Biotech
January 30, 2015 08:30 (CET)
Active Biotech to Present at the 33rd Annual J.P. Morgan Healthcare Conference
January 12, 2015 08:36 (CET)